MEDIUM confidence: 100% data completeness, but the composite (57) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $190M— | $188M-1.4% | $199M+5.9% | $228M+14.9% | $477M+108.8% |
| EPS (dil.) | $0.50— | $0.44-12.0% | $0.50+13.6% | $0.80+60.0% | $1.57+96.3% |
| Free Cash Flow | $151M— | $137M-9.1% | $144M+4.9% | $236M+64.3% | $379M+60.5% |
| Gross Margin | 98.1% | 95.0%-3.1pp | 95.2%+0.2pp | 94.1%-1.1pp | 59.1%-34.9pp |
| Operating Margin | 54.9% | 55.4%+0.5pp | 58.4%+3.0pp | 54.3%-4.1pp | 67.2%+12.8pp |
| Net Margin | 37.8% | -4.0%-41.8pp | 27.1%+31.1pp | 54.8%+27.7pp | 67.3%+12.5pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Avg target $45 (last qtr, 4 analysts) → $45 (last mo, 3) (+0.2%).
Buy-rated share 91% → 92% over ~3 months (+1pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| May 2026 | $0.35 | $0.36 | +1.8% |
| Feb 2026 | $0.39 | $0.47 | +20.5% |
| Nov 2025 | $0.47 | $0.45 | -4.3% |
| Aug 2025 | $0.45 | $0.43 | -4.4% |
| May 2025 | $0.43 | $0.42 | -2.3% |
| Feb 2025 | $0.40 | $0.40 | +0.0% |
| Oct 2024 | $0.38 | $0.38 | +0.0% |
| Aug 2024 | $0.36 | $0.36 | +0.0% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
No recent open-market insider transactions.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
The QScore of 57 for CTRE suggests a neutral outlook, driven by strong growth and momentum scores, which are offset by a lower value score. The stock's growth score is high, reflecting significant revenue and earnings per share growth, as well as a strong 12-month return of 33.8%. However, CTRE trades at a premium, with a P/E of 26.0 and EV/EBITDA of 20.9, contributing to its lower value score. The long-term and short-term scores are relatively aligned, indicating a consistent outlook.